Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
European Journal of Pharmacology|December 25, 2018
Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone painSarah Falk, Camilla Kristine Appel, Heidi Bahrt Bennedbæk, et al.Endocrinology|May 20, 2022
Divergent Roles of α5 and β4 Nicotinic Receptor Subunits in Food Reward and Nicotine-induced Weight Loss in Male MiceAlberte Wollesen Breum, Sarah Falk, Charlotte Sashi Aier Svendsen, et al.Nature Neuroscience|March 19, 2021
Spinal astroglial cannabinoid receptors control pathological tremorEva Maria Meier Carlsen, Sarah Falk, Urszula Skupio, et al.Cell Reports|January 21, 2014
Pain without nociceptors? Nav1.7-independent pain mechanismsMichael S Minett, Sarah Falk, Sonia Santana-Varela, et al.Scientific Reports|July 8, 2017
The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone painCamilla Kristine Appel, Simone Gallego-Pedersen, Line Andersen, et al.Scientific Reports|May 10, 2019
Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone painCamilla Kristine Appel, Simone Gallego-Pedersen, Line Andersen, et al.European Journal of Pharmacology|May 29, 2012
Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in miceRikke Rie Hansen, Arafat Nasser, Sarah Falk, et al.Diabetes|November 4, 2020
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for ObesityPhilippe Zizzari, Rongjun He, Sarah Falk, et al.Nature Communications|February 8, 2024
Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4RCamilla Lund, Pablo Ranea-Robles, Sarah Falk, et al.Cell Reports|May 6, 2023
GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesitySarah Falk, Jonas Petersen, Charlotte Svendsen, et al.Pageof 3